Biomarkers of gastric cancer

Biotherapy

Volumn 23, Issue 2, 2009, Pages 92-97

  Takahashi, Yutaka ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Biomarker of gastric cancer; Epigenetics; Metastasis related genes; Microarray analysis; Serial analysis of gene expression (SAGE)

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CD44V6 ANTIGEN; CYCLIN E; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NEDD8 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN MLH1; PROTEIN P27; PROTEIN P53; RETINOL BINDING PROTEIN 4; SCATTER FACTOR RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 1; THROMBOSPONDIN 1; THY 1 ANTIGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CELL ADHESION; CELL CYCLE REGULATION; DRUG SENSITIVITY; EPIGENETICS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MICROARRAY ANALYSIS; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TUMOR GENE; TUMOR GROWTH; VISCERAL METASTASIS;

EID: 64849115288     PISSN: 09142223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fidler, I.J.: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. clowes memorial award lecture. Cancer Res. 50: 6130-6138, 1990.
2. Japanese source
3. Tahara, E.: Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 119: 265-272, 1993.
4. Yasui, W., Oue, N., Kuniyasu. H., et al.: Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 4:113-121, 2001.
5. Kitadai, Y., Ellis, L.M., Tucker, S.L., et al.: Multi- parametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am. J. Pathol. 149:1541-1551, 1996.
6. Greene, G.F., Kitadai. Y., Pattaway, C.A., et al.: Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol. 150:1571-1582, 1997.
7. Kuniyasu, H., Ellis, L.M., Evans, D.B., et al.: Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin. Cancer Res. 5:25-33, 1999.
8. Herbst, R.S., Yano, S., Kuniyasu, H., et al.: Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin. Cancer Res. 6:790-797, 2000.
9. Takahashi, Y., Kitadai, Y., Ellis, L.M., et al.: Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma. Jpn. J. Cancer Res. 93:1258-1265, 2002.
10. Kim, Y.J., Kim, M.A., Im, S.A., et at. Metastasis- associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 26:152-158, 2008.
11. Gravalos, C. and Jimeno, A.: HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann. Oncol. 19:1523-1529, 2008.
12. Hippo, Y., Taniguchi, H., Tsutsumi, S., et at. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 62:233-240, 2002.
13. Hasegawa, S., Furukawa, Y., Li, M., et at. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23, 040 genes. Cancer Res. 62:7012-7017, 2002.
14. Inoue, H., Matsuyama, A., Mimori, K., et at. Prognostic score of gastric cancer determined by cDNA microarray. Clin. Cancer Res. 8:3475- 3479, 2002.
15. Yang, S. and Chung, H.C.: Novel biomarker candidates for gastric cancer. Oncol. Rep. 19: 675-680, 2008.
16. Yasui, W., Oue, N., Ito, R., et at Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci. 95:385-392, 2004.
17. Yokozaki, H., Yasui, W. and Tahara, E.: Genetic and epigenetic changes in stomach cancer. Int. Rev. Cytol. 204:49-95, 2001.
18. INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J. Pathol. 198:55-59, 2002.
19. Kuraoka, K., Matsumura, S., Hamai, Y., et al.: A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer. Int. J. Cancer 107: 593-596, 2003.
20. Kuraoka, K., Oue, N., Yokozaki, H., et at Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int. J. Oncol. 23:421-427, 2003.
21. Takano, T., Ohe, Y., Kusumoto, M., et at Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib. Lung Cancer 45:93-104, 2004.
22. Pérez-Soler, R.: Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome ? Oncology (Williston Park) 17:23-28, 2003.
23. Takahashi, Y., Sakamoto, J., Takeuchi, T., et at A randomized phase II clinical trial of tailored CPT-ll+S-1 vs S-l in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy. Jpn. J. Clin. Oncol. 34:342-345, 2004.